Search Close


Notice of Results

20th November 2008

Notification of Interim Results

Scancell Holdings Plc, the developer of therapeutic cancer vaccines based on its patented ImmunoBody(tm) platform, today announces that it will release its Interim Results for the six months ended 31 October 2008 during the week commencing
Monday 12th January 2009.

Webcasts, Interviews and Media Coverage

Scancell Holdings lays groundwork for pivotal year

A £3.9mln injection from the life sciences fund Vulpes will effectively bankroll the latest R&D

Tue, 20 Aug 2019 06:05:00

Scancell to begin UK arm of phase II skin cancer trial ‘immediately’

Discussions with US regulators have taken longer than expected, so Scancell will now focus its efforts on completing the UK arm of the trial before re-submitting its US application at a later date

Mon, 19 Aug 2019 06:46:00